Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217
- PMID: 28830966
- DOI: 10.2337/dc17-0465
Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217
Comment in
-
Response to Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217.Diabetes Care. 2017 Sep;40(9):e134. doi: 10.2337/dci17-0019. Diabetes Care. 2017. PMID: 28830967 No abstract available.
Comment on
-
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial.Diabetes Care. 2016 Dec;39(12):2211-2217. doi: 10.2337/dc16-0499. Epub 2016 Oct 6. Diabetes Care. 2016. PMID: 27852684 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
